We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to P&G (PG) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
The upcoming report from Procter & Gamble (PG - Free Report) is expected to reveal quarterly earnings of $1.71 per share, indicating an increase of 7.6% compared to the year-ago period. Analysts forecast revenues of $21.66 billion, representing an increase of 4.3% year over year.
Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain P&G metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net sales- Beauty' of $3.90 billion. The estimate points to a change of +2.5% from the year-ago quarter.
The consensus estimate for 'Net sales- Grooming' stands at $1.73 billion. The estimate points to a change of +5.4% from the year-ago quarter.
It is projected by analysts that the 'Net sales- Corporate' will reach $167.28 million. The estimate points to a change of -4.4% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net sales- Fabric & Home Care' will likely reach $7.40 billion. The estimate indicates a year-over-year change of +5.2%.
Analysts forecast 'Net sales- Baby, Feminine & Family Care' to reach $5.21 billion. The estimate suggests a change of +2.9% year over year.
The consensus among analysts is that 'Net sales- Health Care' will reach $3.23 billion. The estimate suggests a change of +6% year over year.
The average prediction of analysts places 'Organic Sales Growth (YoY change) - Beauty' at 3.5%. Compared to the present estimate, the company reported 3% in the same quarter last year.
Analysts' assessment points toward 'Organic Sales Growth (YoY change) - Total P&G' reaching 4.9%. The estimate compares to the year-ago value of 5%.
Analysts predict that the 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' will reach 4.5%. The estimate compares to the year-ago value of 4%.
Based on the collective assessment of analysts, 'Organic Sales Growth (YoY change) - Fabric & Home Care' should arrive at 6.0%. The estimate compares to the year-ago value of 8%.
According to the collective judgment of analysts, 'Organic Sales Growth (YoY change) - Health Care' should come in at 5.4%. Compared to the present estimate, the company reported 8% in the same quarter last year.
Analysts expect 'Earnings before income taxes- Beauty' to come in at $1.21 billion. Compared to the present estimate, the company reported $1.15 billion in the same quarter last year.
Over the past month, shares of P&G have returned +4.2% versus the Zacks S&P 500 composite's +0.6% change. Currently, PG carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to P&G (PG) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
The upcoming report from Procter & Gamble (PG - Free Report) is expected to reveal quarterly earnings of $1.71 per share, indicating an increase of 7.6% compared to the year-ago period. Analysts forecast revenues of $21.66 billion, representing an increase of 4.3% year over year.
Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain P&G metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net sales- Beauty' of $3.90 billion. The estimate points to a change of +2.5% from the year-ago quarter.
The consensus estimate for 'Net sales- Grooming' stands at $1.73 billion. The estimate points to a change of +5.4% from the year-ago quarter.
It is projected by analysts that the 'Net sales- Corporate' will reach $167.28 million. The estimate points to a change of -4.4% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net sales- Fabric & Home Care' will likely reach $7.40 billion. The estimate indicates a year-over-year change of +5.2%.
Analysts forecast 'Net sales- Baby, Feminine & Family Care' to reach $5.21 billion. The estimate suggests a change of +2.9% year over year.
The consensus among analysts is that 'Net sales- Health Care' will reach $3.23 billion. The estimate suggests a change of +6% year over year.
The average prediction of analysts places 'Organic Sales Growth (YoY change) - Beauty' at 3.5%. Compared to the present estimate, the company reported 3% in the same quarter last year.
Analysts' assessment points toward 'Organic Sales Growth (YoY change) - Total P&G' reaching 4.9%. The estimate compares to the year-ago value of 5%.
Analysts predict that the 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' will reach 4.5%. The estimate compares to the year-ago value of 4%.
Based on the collective assessment of analysts, 'Organic Sales Growth (YoY change) - Fabric & Home Care' should arrive at 6.0%. The estimate compares to the year-ago value of 8%.
According to the collective judgment of analysts, 'Organic Sales Growth (YoY change) - Health Care' should come in at 5.4%. Compared to the present estimate, the company reported 8% in the same quarter last year.
Analysts expect 'Earnings before income taxes- Beauty' to come in at $1.21 billion. Compared to the present estimate, the company reported $1.15 billion in the same quarter last year.
View all Key Company Metrics for P&G here>>>
Over the past month, shares of P&G have returned +4.2% versus the Zacks S&P 500 composite's +0.6% change. Currently, PG carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>